SLN

#3225
Silence Therapeutics Plc American Depository Share
7.50 USD
+22.55%
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
7.08
7.58
Intervallo Annuale
2.63
7.91
Variazione giornaliera
+22.55%
Variazione Mensile
0.00%
Variazione di 6 mesi
+15.74%
Variazione Annuale
+163.16%
Chiusura Precedente
6.12
Apertura
7.25
Bid
Ask
Minimo
7.08
High
7.58
Volume
260
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 354.25 M
  • Employee 88
  • Founded 1994
  • CEO Craig A Tooman
  • Website www.silence-therapeutics.com
  • Headquarter United Kingdom
  • FIGI BBG00WVTHPN2
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-9.65
Rapporto prezzo/fatturato
1 541.15

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

Notizie